Treatment | Duration of release (days) | Bupivacaine concentration (mg/mL) | Meloxicam concentration (mg/mL) | Preclinical dose (mL) |
ER-B-6D | 6 | 176 | 0 | 1.8 |
ER-B/M-6D | 6 | 176 | 35 | 1.8 |
ER-B-3D | 3 | 29 | 0 | 3.4 |
ER-M-3D | 3 | 0 | 1.8 | 1.8 |
ER-B/M-3D | 3 | 29 | 1.8 | 3.4 |
Normal saline | N/A | N/A | N/A | 1.8 |
Liposomal bupivacaine | 3 | 13 | 0 | 8.0 |
3D, 3-day formulation; 6D, 6-day formulation; B, bupivacaine; ER, extended release; M, meloxicam; N/A, not applicable.